This protocol is judged by an institutional assessment board, an independent team that testimonials any clinical trials involving human beings. If a research involves a Agenda I drug, once the board approves the protocol as moral, the scientists must submit an application for an investigational new drug (IND) quantity with the FDA.copyright increas